Company name: GlauCanna venture (Glaucoma treatment company)
Description: Developer of glaucoma treatment therapy or drug. The company’s glaucoma treatment therapy will use medical marijuana in the treatment of glaucoma patients.
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Country: United States
Start up capital raised (USD Million):
Business status: Stealth
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was created as a platform by Mentor Capital on April 13, 2017.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: